Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA®): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high
| Image |  |
|---|---|
| Description | scientific article published on 14 March 2018 |
| Author/s |
author: Michael J Pencina Michaela Mattheus Bernard Zinman Christoph Wanner John H. Alexander Nikolaus Marx Jyothis T George Darren K McGuire Julio Rosenstock Maximilian von Eynatten |
| Publication date | March 14, 2018 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |